Translate
Hls Therapeutics, Inc.
About
Hls Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 1 2026
HLS Therapeutics to Host Q1 2026 Financial Results Conference Call
Apr 14 2026
HLS Therapeutics to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
Mar 12 2026
HLS Therapeutics Announces Fiscal 2025 Financial Results
Mar 5 2026
HLS Therapeutics Announces NILEMDOTM (bempedoic acid) is now available in Canada for the Reduction of LDL-Cholesterol in Patients at Risk of Cardiovascular Disease
Feb 26 2026
HLS Therapeutics to Host Fiscal 2025 Financial Results Conference Call
Recent Videos
HLTRF HLS Therapeutics Inc Dividend History
Mar 17, 2025
"HLS THERAPEUTICS INC (HLS)" Value Analysis - Value Investment Club Readings
Jan 17, 2023
2019 Bloom Burton Award Joint Finalists - Gilbert Godin and Greg Gubitz of HLS Therapeutics Inc.
Sep 30, 2019
HLS Therapeutics Inc. Opens Toronto Stock Exchange March 20, 2019
Mar 20, 2019